New Delhi: The World Health Organization (WHO) may take a decision in the first week of August to include Bharat Biotech’s Corona Vaccine in the Emergency Use List (EUL). This vaccine has been approved for emergency use in India, although the WHO has not yet taken a decision on it.
WHO Chief Scientist Soumya Swaminathan, while addressing a webinar organized by the Center for Science and Environment (CSE) on Friday, said that Bharat Biotech, the manufacturer of the vaccine, is uploading all its data on our portal and WHO is reviewing this vaccine. has been.
EUL is a process by which new or unlicensed products can be used in public health emergencies as per WHO guidelines.
Swaminathan said, ‘‘EUL is a process in which a company has to complete Phase III trials and submit all the data to the regulatory department of WHO which is studied by an expert advisory group. ’
He said, ‘‘Full data is provided including safety and effectiveness and production quality standards. Bharat Biotech has already submitted the data and I hope to take a decision on the inclusion of the vaccine in four to six weeks.’’
Currently WHO has approved vaccines for emergency use from Pfizer-BioNtech, AstraZeneca-SK Bio-Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm.
Swaminathan said, ‘‘As of now we have approved six vaccines with EUL and recommendations have been received from our Strategic Expert Consultative Group. We are optimistic about Covaccine. Bharat Biotech has started putting their data on our portal and this will be the next vaccine to be reviewed by our expert committee.’’